These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1615024)

  • 1. [Potential cardiotonics. 13. Crystal structure, charge distribution and molecular electrostatic potential of 3-cyano-2-(3-diethyl-aminopropylamino)-5-(4-pyridinyl)pyridine (AWD 122-60)].
    Reck G; Hagen V; Labes D
    Pharmazie; 1992 Mar; 47(3):192-4. PubMed ID: 1615024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential cardiotonics. 16. Molecular and crystal structures of three polymorphic forms and a hydrochloride monohydrate of 3-cyano-2-morpholino-5-(pyridin-4-yl)pyridine (AWD 122-14)].
    Reck G; Hagen V; Bannier G
    Pharmazie; 1992 Nov; 47(11):852-6. PubMed ID: 1492114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potential cardiotonic agents. 10. Synthesis and positive inotropic action of 5-(4-pyridinyl)- and 5-phenyl-substituted 2-alkylthio-3-cyan-pyridines and their S-oxidation products].
    Rumler A; Hagen V; Hagen A
    Pharmazie; 1990 Sep; 45(9):657-9. PubMed ID: 2284307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potential cardiotonic agents. 8. 2-acyloxyalkylamino-, 2-acyloxyalkoxy-, and 2-acylaminoalkylamino-3-cyan-5-(pyrid-4-yl) pyridine].
    Hagen V; Klauschenz E; Rumler A; Niedrich H; Hagen A; Heer S; Mitzner R
    Pharmazie; 1990 May; 45(5):343-5. PubMed ID: 2395896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential cardiotonic agents. 4. Synthesis, cardiovascular activity, molecular and crystal structure of 5-phenyl- and 4-(4-pyridinyl)-substituted 2(1H)-pyridinethiones].
    Hagen V; Rumler A; Reck G; Hagen A; Labes D; Heer S
    Pharmazie; 1989 Dec; 44(12):809-13. PubMed ID: 2635317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Potential cardiotonics. 15. Crystal modifications of 3-cyano-2-morpholino-5-(4-pyridinyl)pyridine (AWD 122-14)].
    Hagen V; Reck G; Dathe M; Jänsch HJ; Feist M
    Pharmazie; 1992 Oct; 47(10):777-80. PubMed ID: 1480657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential cardiotonics. 7. Synthesis and cardiovascular effects of 5-(4-pyridinyl)-, 6-methyl-4-(4-pyridinyl) and 6-methyl-5-phenyl-substituted 3-cyano-2-aminoalkylamino-pyridines].
    Hagen V; Rumler A; Klauschenz E; Hagen A; Heer S; Faust G; Mitzner R
    Pharmazie; 1990 Apr; 45(4):240-1. PubMed ID: 2381972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
    Roloff B; Schäfer J; Rumler A; Hagen V; Hagen A
    Pharmazie; 1989 Dec; 44(12):859-60. PubMed ID: 2635323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Potential cardiotonic agents. 6. Synthesis and cardiovascular properties of 5-(4-pyridinyl)-, 6-methyl-5-(4-pyridinyl)- and 6-methyl-5-phenyl-substituted 3-cyano-2-oxaalkyoxy-pyridines].
    Hagen V; Klauschenz E; Rumler A; Hagen A; Heer S; Mitzner R; Niedrich H; Lohmann D
    Pharmazie; 1990 Mar; 45(3):189-90. PubMed ID: 2381960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential cardiotonic agents. 2. Synthesis and pharmacologic properties of 5-(pyri-4-yl)- and 5-phenyl substituted 3-cyano-6-methyl-2-oxaalkylaminopyridines].
    Klauschenz E; Rumler A; Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):23-5. PubMed ID: 2727023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
    Hagen V; Hagen A; Krause EG; Klauschenz E
    Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential cardiotonic agents. 1. Synthesis and pharmacologic properties of 3-cyano-2-oxaalkylamino-5-(4-pyridinyl)pyridines].
    Hagen V; Hagen A; Heer S; Mitzner R; Niedrich H
    Pharmazie; 1989 Jan; 44(1):20-3. PubMed ID: 2727022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthesis of positive inotropic substances: imidazolylpropylguanidines with partial pyridine structure].
    Buschauer A
    Arch Pharm (Weinheim); 1988 Jul; 321(7):415-8. PubMed ID: 3219057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and positive inotropic action of some 5-substituted 5H-(1)benzopyrano(4,3-b)pyridines].
    Heber D; Ravens U
    Arzneimittelforschung; 1985; 35(11):1624-6. PubMed ID: 4091865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridazine analogues of biologically active compounds. Part 5: Novel potential cardiotonics of the amrinone type.
    Haider N; Heinisch G; Offenberger S
    Pharmazie; 1989 Sep; 44(9):598-601. PubMed ID: 2608703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the mapping of electrostatic properties from the multipole description of the charge density.
    Su Z; Coppens P
    Acta Crystallogr A; 1992 Mar; 48 ( Pt 2)():188-97. PubMed ID: 1575938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the conformational structure of bipyridine cardiotonics.
    Hofmann HJ; Birner P
    Pharmazie; 1987 Jun; 42(6):414-5. PubMed ID: 3671463
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular crystals: the crystal field effect on molecular electronic structure.
    Yatsenko AV
    J Mol Model; 2003 Aug; 9(4):207-16. PubMed ID: 12838399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics.
    Robertson DW; Krushinski JH; Pollock GD; Hayes JS
    J Med Chem; 1988 Feb; 31(2):461-5. PubMed ID: 3339616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.